Table 1 Prevalence of cryptococcal antigenaemia (CrAg) by demographic and clinical characteristics
Total number tested for CrAg (% of total) | Number CrAg positive | Prevalence of CrAg % (95%CI) | P-value (Fisher’s exact) | |
|---|---|---|---|---|
Total | 170 | 8 | 4.7 (2.4–9.2) | |
Sex | 0.144 | |||
Male | 69 (40.6) | 1 | 1.4 (0.2–10.0) | |
Female | 101 (59.4) | 7 | 6.9 (3.3–14.0) | |
Age (years) | 1.000 | |||
< 35 | 64 (37.6) | 3 | 4.7 (1.5–13.9) | |
≥35 | 106 (62.4) | 5 | 4.7 (1.9–11.0) | |
Admission status | 0.287 | |||
Outpatient | 79 (46.5) | 2 | 2.5 (0.6–9.8) | |
Inpatient | 91 (53.5) | 6 | 6.6 (2.9–14.1) | |
CD4 (cells/mm3) | 1.000 | |||
< 50 | 96 (56.5) | 5 | 5.2 (0.7–9.7) | |
≥ 50 | 74 (43.5) | 3 | 4.1 (0.0–8.7) | |
Time since HIV diagnosis (days) | 0.278 | |||
< 90 “newly diagnosed” | 86 (50.6) | 6 | 7.0 (3.1–14.9) | |
≥ 90 | 84 (49.4) | 2 | 2.4 (0.6–9.5) | |
Previous antiretroviral therapy (ART)a | 0.468 | |||
ART naïve or newly-initiated | 91 (56.2) | 6 | 6.6 (2.9–14.1) | |
ART experienced | 71 (43.8) | 2 | 2.8 (0.7–10.9) | |
On ART at time of recruitmenta | 1.000 | |||
Yes | 43 (26.9) | 2 | 4.7 (1.1–17.6) | |
No | 117 (73.1) | 6 | 5.1 (2.3–11.1) | |